Fig. 17.1
(a) A Nasal Endoscopy set up. (b) A Balloon Dacryoplasty armamentarium. (c) The inflatable end of a 2 mm balloon catheter. (d) The hub of a 2 mm balloon catheter with luer-lock mechanism, which engages the inflation device
(a)
2, 3, 5, or 9 mm balloon catheters
(b)
Inflation device
(c)
Lacrimal Probes
(d)
Punctum dilator
(e)
Dandy’s Nerve hook
(f)
Intubation set with retrieval device
Balloon catheters are specially designed with an inflatable balloon at one end of the catheter (Fig. 17.1c) and hub with luer-lock mechanism at the other which engages the inflation device (Fig. 17.1d). Two millimeter balloon catheters are named so since they have an outer diameter of 2 mm during an inflated stage. The length of this balloon is 13 mm. Similarly 3 mm balloon has an outer diameter of 3 mm but the length is 15 mm. The 5 mm (Fig. 17.2a) and 9 mm (Fig. 17.2b) balloons have outer diameters of 5 mm and 9 mm respectively but their length is 8 mm. Nine millimeter balloon catheter is much sturdier and is angulated at 120° focused within the balloon segment. Two important markings on the 2 and 3 mm catheters are the 10 and 15 mm black marks to serve as a guide when the catheters are within the nasolacrimal ducts (Fig. 17.2c).
Fig. 17.2
(a) A 5 mm balloon catheter. It is a bit curved unlike the 2 and 3 mm ones which are straight. (b) A 9 mm balloon catheter. Note the robust body and 90° angulation near the balloon end. (c) Two important markings on the 2 and 3 mm catheters are the 10 and 15 mm black marks to serve as a guide when the catheters are within the nasolacrimal ducts. (d) Inflation device with the manometer at one end and locking device and the knob at the other end
The inflation device has a manometer which displays the pressure reading in atmospheres (Fig. 17.2d). Proximal end of the manometer has a tube with a luer-lock adaptor for attachment to the catheters and the distal end has a locking device and a knob. When the locking device is to the left, it indicates an unlocked stage, whereas if it is to right, it indicates a locked stage. The knob when rotated clockwise with the manometer in locked stage, steadily increases the pressure within the device and inflates the balloon whereas its anti-clockwise rotation reduces the pressure and thus deflates the balloon. Preoperative and Intraoperative nasal endoscopic examination is essential for these procedures (Fig. 17.3a).
Fig. 17.3
(a) Nasal endoscopic examination before a balloon dacryoplasty procedure. (b) A child with right CNLD. Note the increased tear meniscus height as well as matting of lashes with discharge. (c) An I-Probe with black markings. Note the small opening on one side of the probe. (d) A balloon catheter in action. Note the markings which reflect the position of the balloon in the nasolacrimal duct
Balloon Dacryoplasty in Children
Syringing and Probing has been a standard of care for congenital nasolacrimal duct obstructions (CNLDO) (Fig. 17.3b). Although it is a very good procedure with high success rates, the same is not true for older children [3, 4]. Probing is less effective in older children because of complex blocks or diffused narrowing of the nasolacrimal duct [5, 6]. Silicone intubations are generally carried out in older children or those who fail probing but the drawbacks of these procedures in children including stent prolapse, second sitting for removal of tubes, and keeping them in situ for 2–3 months need to be taken into account [7].
Balloon dilatation came into vogue because it achieves true dilatations of narrowed segments, easier to perform than primary silicone intubation with good success rates. A 2 mm balloon is used for patients less than 30 months of age and 3 mm for children more than 30 months of age. The indications of balloon dacryoplasty for congenital nasolacrimal duct obstructions [1, 6, 8, 9] are:
(a)
Failed Probing
(b)
Failed intubation
(c)
Older children (>12 months of age)
(d)
Down’s syndrome or any syndromic association with CNLDO
Operative Procedure
Preoperative preparation includes decongestion of the inferior meatus with 0.05 % Oxymetazoline. Two drops can be placed half an hour before the procedure or alternatively a cottonoid soaked with the drug can be placed in inferior meatus for 5 min before the procedure. Following dilatation of the puncta, a probing is performed as a standard procedure and the probe is inspected in the inferior meatus to confirm that all the blocks are overcome. An I-probe (Quest Medical Inc, Allen, Texas, USA) can be used which is similar to a bowman’s probe with a small eyelet near the tip to wash off the debris following probing and also to reflect on the free flow following probing (Fig. 17.3c). Inferior turbinate medialization may occasionally be needed along with probing if it appears to be impacted to the lateral wall.
The sleeve of the balloon is removed, it is then lubricated with either a viscoelastic or a 1 % carboxymethycellulose drops and gently placed into the lacrimal system just like the procedure of probing and introduced further into the nasolacrimal duct till the 15 mm mark is adjoining the puncta (Fig. 17.3d) or the balloon exits just beyond the valve of Hasner as seen with nasal endoscopy. In the meantime the inflation device filled with saline or fluorescent-stained saline (Fig. 17.4a) should be ready in the locked position (Fig. 17.4b). The air should be removed from the device after saline filling. The luer-lock hub of the inflation device is connected to the catheter (Fig. 17.4c) and the knob is slowly rotated in the clockwise direction (Fig. 17.4d) by the assistant while the surgeon can be visualizing the dilatation of the balloon via the endoscope.
Fig. 17.4
(a) Saline filling of the inflation device. (b) Locking of the inflation device. (c) The hub of the balloon catheter engaging the inflation device by a luer-lock mechanism. (d) The final and complete assembly of catheter and inflation device
The balloons are inflated to 8 atm of pressure for a duration of 90 s (Fig. 17.5a). The inflated balloon should be under constant monitoring in the nose (Fig. 17.5b). The knob of the inflation device is then rotated in an anti-clockwise manner to deflate the balloon. Once deflated, without disturbing the catheters position, it is reinflated to 8 atm for 60 s. The balloon is again deflated (Fig. 17.5c) and pulled back till the 10 mm mark adjoins the punctum or the tip of the balloon is barely visible proximal to valve of Hasner (Fig. 17.5c). The two cycles of inflation and deflation are carried out again in this position. The catheter and the inflation device are then disconnected followed by gentle withdrawal of the catheter from the lacrimal system. The lacrimal passages are then irrigated with either saline or fluorescein-stained saline (Fig. 17.6a). The fluid should flow easily and in copious amounts indicating success of the procedure. The saline from the inflation device is then emptied after unlocking the device (Fig. 17.6b).
Fig. 17.5
(a) Manometer of the inflation device showing that the pressure of 8 atm has reached. (b) Endoscopic view showing the distal dilatation of the nasolacrimal duct. Note the inflated balloon. (c) Endoscopic view showing the deflated stage of the balloon catheter. (d) Endoscopic view showing the beginning of proximal dilatation of the nasolacrimal duct
Fig. 17.6
(a) Endoscopic view showing fluorescein-stained saline freely flowing in the inferior meatus. (b) The saline from the inflation device being drained out at the end of the procedure. (c) Endoscopic view showing the dilated NLD as well as the silicone stent coming out of the NLD. Note the clearly seen NLD mucosa. (d) I-Stents. Note the thinner central segment contiguous with thicker segments on either side